2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$3.46-$0.14 (-3.89%)
Price as of Jun 03, 2026 7:38 PM EDT- $162.5MMarket Cap
- 70.87%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$3.46-$0.14 (-3.89%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.0M N/A | N/A N/A | 1.3M -50.43% | 2.7M 0.00% | |
Cost of Revenue | 2.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 13,000 N/A | 0 -100.00% | 1.3M -50.43% | 2.7M 0.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | -287,000 -115.51% | 1.9M N/A | |
Research and Development Expense | -6.4M +0.90% | -6.3M -29.51% | -9.0M -67.54% | -27.6M +31.68% | |
Depreciation and Amortization Expense | 121,000 -37.31% | 193,000 -1.53% | 196,000 +237.93% | 58,000 -24.68% | |
Total Operating Expenses | 8.7M +35.05% | 6.5M -23.36% | 8.4M +3,091.29% | 264,000 -95.55% | |
Operating Profit | -15.1M +18.05% | -12.8M -18.95% | -15.8M -61.16% | -40.6M +67.60% | |
Interest Income | 2.4M -54.71% | 5.2M +52,290.00% | 10,000 N/A | N/A N/A | |
Interest Expense | N/A N/A | -2.6M +27.00% | -2.0M N/A | N/A N/A | |
Interest Income and Expense and Net | 2.4M -10.52% | 2.7M +230.83% | -2.0M N/A | 0 N/A | |
Total Nonoperating Income and Expense | 89.5M +4,013.12% | -2.3M -109.99% | 22.9M +559.20% | 3.5M +2,571.54% | |
Income before Taxes | 75.3M +573.14% | -15.9M -412.89% | 5.1M +113.51% | -37.7M -263.83% | |
Income Taxes | 11.3M +255.26% | 3.2M N/A | N/A N/A | 100,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 64.0M +435.29% | -19.1M -445.76% | 5.5M +114.63% | -37.8M +64.27% | |
Net Income from Continuing Operations Applicable to Common | 75.3M +573.14% | -15.9M -412.89% | 5.1M +113.92% | -36.6M -259.04% | |
Basic EPS and Net Income | 1.53 +418.75% | -0.48 -442.86% | 0.14 -85.11% | 0.94 +20.51% | |
Diluted EPS and Net Income | 1.50 +412.50% | -0.48 -442.86% | 0.14 -85.11% | 0.94 +20.51% | |
Basic Weighted Average Shares | 41.4M +1.41% | 40.8M +1.27% | 40.3M +3.38% | 39.0M +36.98% | |
Diluted Weighted Average Shares | 42.4M +3.89% | 40.8M +0.64% | 40.6M +4.02% | 39.0M +36.98% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 45.9M -15.57% | 54.4M +500.99% | 9.1M -77.62% | 40.5M -47.62% | |
Short-Term Investments | 5.4M +57.43% | 3.4M -94.04% | 57.7M +1,441.89% | 3.7M -36.03% | |
Cash and Cash Equivalents and Short-Term Investments | 51.4M -11.23% | 57.9M -13.34% | 66.8M +51.03% | 44.2M -46.80% | |
Total Current Assets | 133.3M -6.95% | 143.2M -11.91% | 162.6M +3.48% | 157.1M +64.79% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 586,000 -16.05% | 698,000 -20.05% | 873,000 +7.12% | 815,000 +105.29% | |
Total Long-Term Assets | 97.6M +709.43% | 12.1M -79.20% | 58.0M +1,178.78% | 4.5M -86.12% | |
Total Assets | 230.9M +48.68% | 155.3M -29.60% | 220.6M +36.44% | 161.6M +26.28% | |
Income Taxes Payable | 7.9M +146.91% | 3.2M +29,027.27% | 11,000 N/A | N/A N/A | |
Total Short-Term Debt | 652,000 +98.18% | 329,000 -99.36% | 51.3M +5,133,700.00% | 1,000 -98.15% | |
Total Current Liabilities | 19.1M +235.73% | 5.7M -89.32% | 53.2M +826.11% | 5.7M -13.97% | |
Total Long-Term Debt | 850,000 -81.26% | 4.5M N/A | N/A N/A | 25,000 -99.90% | |
Total Long-Term Liabilities | 12.0M +183.42% | 4.2M -4.46% | 4.4M -6.24% | 4.7M -1.31% | |
Total Liabilities | 19.6M +236.00% | 5.8M -89.09% | 53.6M +737.73% | 6.4M -4.28% | |
Retained Earnings | -123.4M -30.11% | -176.6M +12.10% | -157.6M -3.39% | -163.1M +41.99% | |
Total Stockholders Equity | 199.7M +36.56% | 146.3M -10.72% | 163.8M +7.91% | 151.8M +31.13% | |
Total Shares Outstanding | 39.3M -1.61% | 39.9M -1.04% | 40.3M +1.96% | 39.6M +12.10% | |
Cash Flow | |||||
Cash from Operating Activities | -9.1M +8.71% | -8.4M -18.29% | -10.3M -63.12% | -27.9M +31.81% | |
Capital Expenditures | 9,000 -50.00% | 18,000 -92.91% | 254,000 -48.79% | 496,000 +32.27% | |
Cash from Investing Activities | 5.4M -94.86% | 105.8M +244.88% | -73.0M -341.76% | 30.2M +227.13% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -4.7M -90.89% | -52.0M -200.11% | 52.0M +382.22% | 10.8M -89.52% | |
Financials Ratio | |||||
Gross Margin | 0.65% N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -754.40% N/A | N/A N/A | -1,176.79% -21.65% | -1,501.96% +67.60% | |
Return on Assets | 33.17% +426.33% | -10.17% -451.61% | 2.89% +111.09% | -26.08% -2.09% | |
Return on Equity | 37.02% +400.48% | -12.32% -451.94% | 3.50% +112.40% | -28.23% -8.74% | |
Revenue Growth | N/A N/A | N/A N/A | -50.43% N/A | 0.00% +100.00% | |
Current Ratio | 6.98 -72.28% | 25.19 +724.56% | 3.06 -88.83% | 27.34 +91.55% | |
Cash Ratio | 2.41 -74.85% | 9.57 +5,524.32% | 0.17 -97.58% | 7.04 -39.11% | |
Debt-to-Equity Ratio | 0.008 -77.48% | 0.03 N/A | N/A N/A | 0.0002 -99.91% | |
Debt-to-Assets Ratio | 0.007 -79.23% | 0.03 N/A | N/A N/A | 0.0002 -99.90% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow